Pulse Biosciences, Inc. Payments to Acquire Marketable Securities
Pulse Biosciences, Inc. (PLSE) reported Payments to Acquire Marketable Securities of $19.16 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2018-05-08
- Pulse Biosciences, Inc. payments to acquire marketable securities for the quarter ending 2018-03-31 was $19.16M, a 151.73% increase year-over-year.
- Pulse Biosciences, Inc. payments to acquire marketable securities for the quarter ending 2017-12-31 was $32.23M, a 548.40% increase year-over-year.
- Pulse Biosciences, Inc. payments to acquire marketable securities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. payments to acquire marketable securities for the quarter ending 2017-06-30 was $3.75M.
- Pulse Biosciences, Inc. payments to acquire marketable securities for fiscal 2017 was $43.59M, a 128.64% increase from fiscal 2016.
- Pulse Biosciences, Inc. payments to acquire marketable securities for fiscal 2016 was $19.07M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2018-03-31 | $19.16M 10-Q · filed 2018-05-08 | $51.39M derived: sum of 2 quarters · filed 2018-05-08 | $51.39M derived: sum of 3 quarters · filed 2018-05-08 | $55.14M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $32.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $32.23M derived: sum of 2 quarters · filed 2018-03-16 | $35.98M derived: sum of 3 quarters · filed 2018-03-16 | $43.59M 10-K · filed 2018-03-16 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $3.75M derived: sum of 2 quarters · filed 2017-11-08 | $11.36M 10-Q · filed 2017-11-08 | $16.33M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $11.36M 10-Q · filed 2017-08-10 | $16.33M derived: sum of 3 quarters · filed 2018-05-08 | $29.93M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $7.61M 10-Q · filed 2018-05-08 | $12.58M derived: sum of 2 quarters · filed 2018-05-08 | $26.18M derived: sum of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $18.57M derived: sum of 2 quarters · filed 2018-03-16 | $19.07M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $13.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $14.10M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $495.00K 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |